Literature DB >> 31806194

Excess Costs and Economic Burden of Obesity-Related Cancers in the United States.

Young-Rock Hong1, Jinhai Huo2, Raj Desai2, Michelle Cardel3, Ashish A Deshmukh4.   

Abstract

BACKGROUND: Obesity is a significant risk factor of several cancers that imposes a substantial economic burden on US healthcare that remains to be quantified. We estimated the excess costs and economic burden of obesity-related cancers in the United States.
METHODS: From the Medical Expenditure Panel Survey (2008-2015) data, we identified 19 405 cancer survivors and 175 498 non-cancer individuals. We estimated annual health expenditures using generalized linear regression with log link and gamma distribution by cancer types (stratified by 11 obesity-related cancers and other cancer types), controlling for sociodemographic and clinical characteristics. All cost estimates were adjusted to 2015 USD value.
RESULTS: The average annual total health expenditures were $21 503 (95% CI, $20 946-$22 061) for those with obesity-related cancer and $13 120 (95% CI, $12 920-$13 319) for those with other cancer types. There was a positive association between body mass index and health expenditures among cancer survivors: for each additional 5-unit increase in body mass index, the average predicted expenditures increase by $1503 among those with obesity-related cancer and by $722 among those with other cancers. With adjustments for sociodemographic and clinical characteristics, the mean incremental expenditures of treating obesity-related cancer were 2.1 times higher than those of other cancers ($4492 vs $2139) and more considerable among the non-elderly cancer population. Obesity-related cancers accounted for nearly 43.5% of total direct cancer care expenditures, estimated at $35.9 billion in 2015.
CONCLUSION: The economic burden of obesity-related cancer in the United States is substantial. Our findings suggest a need for the inclusion of comprehensive obesity prevention and treatment in cancer care.
Copyright © 2019. Published by Elsevier Inc.

Entities:  

Keywords:  cancer burden in the United States; economic burden of cancer; excess costs of cancer care; obesity-related cancer

Mesh:

Year:  2019        PMID: 31806194      PMCID: PMC7313233          DOI: 10.1016/j.jval.2019.07.004

Source DB:  PubMed          Journal:  Value Health        ISSN: 1098-3015            Impact factor:   5.725


  27 in total

1.  Cancer statistics, 2018.

Authors:  Rebecca L Siegel; Kimberly D Miller; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2018-01-04       Impact factor: 508.702

2.  Incorporating Weight Management into Clinical Care for Cancer Survivors: Challenges, Opportunities, and Future Directions.

Authors:  Rishi Jain; Crystal S Denlinger
Journal:  Obesity (Silver Spring)       Date:  2017-11       Impact factor: 5.002

3.  The medical expenditure panel survey: a national information resource to support healthcare cost research and inform policy and practice.

Authors:  Joel W Cohen; Steven B Cohen; Jessica S Banthin
Journal:  Med Care       Date:  2009-07       Impact factor: 2.983

4.  Obesity and mortality in elderly nursing home residents.

Authors:  David C Grabowski; Christine M Campbell; John E Ellis
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2005-09       Impact factor: 6.053

5.  Body Fatness and Cancer--Viewpoint of the IARC Working Group.

Authors:  Béatrice Lauby-Secretan; Chiara Scoccianti; Dana Loomis; Yann Grosse; Franca Bianchini; Kurt Straif
Journal:  N Engl J Med       Date:  2016-08-25       Impact factor: 91.245

6.  Increasing disparities in the age-related incidences of colon and rectal cancers in the United States, 1975-2010.

Authors:  Christina E Bailey; Chung-Yuan Hu; Y Nancy You; Brian K Bednarski; Miguel A Rodriguez-Bigas; John M Skibber; Scott B Cantor; George J Chang
Journal:  JAMA Surg       Date:  2015-01       Impact factor: 14.766

Review 7.  Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies.

Authors:  Andrew G Renehan; Margaret Tyson; Matthias Egger; Richard F Heller; Marcel Zwahlen
Journal:  Lancet       Date:  2008-02-16       Impact factor: 79.321

8.  Total Lifetime and Cancer-related Costs for Elderly Patients Diagnosed With Anal Cancer in the United States.

Authors:  Ashish A Deshmukh; Hui Zhao; Luisa Franzini; David R Lairson; Elizabeth Y Chiao; Prajnan Das; Michael D Swartz; Sharon H Giordano; Scott B Cantor
Journal:  Am J Clin Oncol       Date:  2018-02       Impact factor: 2.339

9.  The Relationship of Obesity to Hospice Use and Expenditures: A Cohort Study.

Authors:  John A Harris; Elena Byhoff; Chithra R Perumalswami; Kenneth M Langa; Alexi A Wright; Jennifer J Griggs
Journal:  Ann Intern Med       Date:  2017-02-07       Impact factor: 25.391

10.  Health Effects of Overweight and Obesity in 195 Countries over 25 Years.

Authors:  Ashkan Afshin; Mohammad H Forouzanfar; Marissa B Reitsma; Patrick Sur; Kara Estep; Alex Lee; Laurie Marczak; Ali H Mokdad; Maziar Moradi-Lakeh; Mohsen Naghavi; Joseph S Salama; Theo Vos; Kalkidan H Abate; Cristiana Abbafati; Muktar B Ahmed; Ziyad Al-Aly; Ala’a Alkerwi; Rajaa Al-Raddadi; Azmeraw T Amare; Alemayehu Amberbir; Adeladza K Amegah; Erfan Amini; Stephen M Amrock; Ranjit M Anjana; Johan Ärnlöv; Hamid Asayesh; Amitava Banerjee; Aleksandra Barac; Estifanos Baye; Derrick A Bennett; Addisu S Beyene; Sibhatu Biadgilign; Stan Biryukov; Espen Bjertness; Dube J Boneya; Ismael Campos-Nonato; Juan J Carrero; Pedro Cecilio; Kelly Cercy; Liliana G Ciobanu; Leslie Cornaby; Solomon A Damtew; Lalit Dandona; Rakhi Dandona; Samath D Dharmaratne; Bruce B Duncan; Babak Eshrati; Alireza Esteghamati; Valery L Feigin; João C Fernandes; Thomas Fürst; Tsegaye T Gebrehiwot; Audra Gold; Philimon N Gona; Atsushi Goto; Tesfa D Habtewold; Kokeb T Hadush; Nima Hafezi-Nejad; Simon I Hay; Masako Horino; Farhad Islami; Ritul Kamal; Amir Kasaeian; Srinivasa V Katikireddi; Andre P Kengne; Chandrasekharan N Kesavachandran; Yousef S Khader; Young-Ho Khang; Jagdish Khubchandani; Daniel Kim; Yun J Kim; Yohannes Kinfu; Soewarta Kosen; Tiffany Ku; Barthelemy Kuate Defo; G Anil Kumar; Heidi J Larson; Mall Leinsalu; Xiaofeng Liang; Stephen S Lim; Patrick Liu; Alan D Lopez; Rafael Lozano; Azeem Majeed; Reza Malekzadeh; Deborah C Malta; Mohsen Mazidi; Colm McAlinden; Stephen T McGarvey; Desalegn T Mengistu; George A Mensah; Gert B M Mensink; Haftay B Mezgebe; Erkin M Mirrakhimov; Ulrich O Mueller; Jean J Noubiap; Carla M Obermeyer; Felix A Ogbo; Mayowa O Owolabi; George C Patton; Farshad Pourmalek; Mostafa Qorbani; Anwar Rafay; Rajesh K Rai; Chhabi L Ranabhat; Nikolas Reinig; Saeid Safiri; Joshua A Salomon; Juan R Sanabria; Itamar S Santos; Benn Sartorius; Monika Sawhney; Josef Schmidhuber; Aletta E Schutte; Maria I Schmidt; Sadaf G Sepanlou; Moretza Shamsizadeh; Sara Sheikhbahaei; Min-Jeong Shin; Rahman Shiri; Ivy Shiue; Hirbo S Roba; Diego A S Silva; Jonathan I Silverberg; Jasvinder A Singh; Saverio Stranges; Soumya Swaminathan; Rafael Tabarés-Seisdedos; Fentaw Tadese; Bemnet A Tedla; Balewgizie S Tegegne; Abdullah S Terkawi; J S Thakur; Marcello Tonelli; Roman Topor-Madry; Stefanos Tyrovolas; Kingsley N Ukwaja; Olalekan A Uthman; Masoud Vaezghasemi; Tommi Vasankari; Vasiliy V Vlassov; Stein E Vollset; Elisabete Weiderpass; Andrea Werdecker; Joshua Wesana; Ronny Westerman; Yuichiro Yano; Naohiro Yonemoto; Gerald Yonga; Zoubida Zaidi; Zerihun M Zenebe; Ben Zipkin; Christopher J L Murray
Journal:  N Engl J Med       Date:  2017-06-12       Impact factor: 91.245

View more
  7 in total

1.  Trends and drivers of pharmaceutical expenditures from systemic anti-cancer therapy.

Authors:  Lars Børty; Rasmus F Brøndum; Heidi S Christensen; Charles Vesteghem; Marianne Severinsen; Søren P Johnsen; Lars H Ehlers; Ursula Falkmer; Laurids Ø Poulsen; Martin Bøgsted
Journal:  Eur J Health Econ       Date:  2022-08-26

2.  Costs of multimorbidity: a systematic review and meta-analyses.

Authors:  Phuong Bich Tran; Joseph Kazibwe; Georgios F Nikolaidis; Ismo Linnosmaa; Mieke Rijken; Josefien van Olmen
Journal:  BMC Med       Date:  2022-07-19       Impact factor: 11.150

3.  The future costs of cancer attributable to excess body weight in Brazil, 2030-2040.

Authors:  Leandro F M Rezende; Thainá Alves Malhão; Rafael da Silva Barbosa; Arthur Orlando Correa Schilithz; Ronaldo Corrêa Ferreira da Silva; Luciana Grucci Maya Moreira; Paula Aballo Nunes Machado; Bruna Pitasi Arguelhes; Maria Eduarda Leão Diogenes Melo
Journal:  BMC Public Health       Date:  2022-06-21       Impact factor: 4.135

4.  Attrition Bias in an Observational Study of Very Low-Energy Diet: A Cohort Study.

Authors:  Deanna J M Isaman; William H Herman; Amy E Rothberg
Journal:  Obesity (Silver Spring)       Date:  2020-11-16       Impact factor: 5.002

Review 5.  The ambiguous role of obesity in oncology by promoting cancer but boosting antitumor immunotherapy.

Authors:  José Antônio Fagundes Assumpção; Gabriel Pasquarelli-do-Nascimento; Mariana Saldanha Viegas Duarte; Martín Hernan Bonamino; Kelly Grace Magalhães
Journal:  J Biomed Sci       Date:  2022-02-14       Impact factor: 8.410

6.  Supporting Management of Noncommunicable Diseases With Mobile Health (mHealth) Apps: Experimental Study.

Authors:  Neta Kela; Eleanor Eytam; Adi Katz
Journal:  JMIR Hum Factors       Date:  2022-03-02

7.  An ecological study of obesity-related cancer incidence trends in Australia from 1983 to 2017.

Authors:  Eleonora Feletto; Ankur Kohar; David Mizrahi; Paul Grogan; Julia Steinberg; Clare Hughes; Wendy L Watson; Karen Canfell; Xue Qin Yu
Journal:  Lancet Reg Health West Pac       Date:  2022-09-06
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.